Table 2 C‐reactive protein (CRP) and cardiovascular risk in healthy individuals.
| Study | End point | Relative risk (95% CI) |
|---|---|---|
| Tracy et al13 | Myocardial infarction | 2.67 (1.04 to 6.81) |
| Ridker et al14 | Myocardial infarction | 2.9 (1.8 to 4.6) |
| Ridker et al14 | Stroke | 1.9 (1.1 to 3.3) |
| Ridker et al15 | Peripheral vascular disease | 2.2 (1.1 to 4.8) |
| Ridker et al16 | Any vascular event | 4.8 (2.3 to 10.1) |
| Ridker et al16 | Myocardial infarction or stroke | 7.3 (2.7 to 19.9 |
| Roivainen et al17 | Coronary heart disease | 3.56 (1.93 to 6.57) |
| Ridker et al2 | Cardiovascular events | 4.4 (2.2 to 8.9) |
| Rost et al18 | Stroke | 1.9 (1.1 to 3.3) |
| Lowe et al19 | Ischaemic heart disease | 2.73 (1.6 to 4.7) |
| Ridker et al20 | Cardiovascular disease | 3.6 (2.5 to 5.2) |
| Danesh et al6 | Coronary heart disease | 2.13 (1.38 to 3.28) |
| Boekholdt et al21 | Coronary artery disease | 2.49 (2.02 to 3.08) |
| Fatal | 2.92 (1.83 to 4.67) | |
| Non‐fatal | 1.25 (0.93 to 1.66) | |
| Ridker et al22 | Coronary artery disease | 2.98 (1.90 to 4.67) |